JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dadachova, E.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dadachova, E.
Right arrow Articles by Casadevall, A.
Journal of Nuclear Medicine Vol. 45 No. 2 313-320
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Susceptibility of the Human Pathogenic Fungi Cryptococcus neoformans and Histoplasma capsulatum to {gamma}-Radiation Versus Radioimmunotherapy with {alpha}- and ß-Emitting Radioisotopes

Ekaterina Dadachova, PhD1, Roger W. Howell, PhD2, Ruth A. Bryan, PhD1, Annie Frenkel, BA1, Joshua D. Nosanchuk, MD3 and Arturo Casadevall, MD, PhD3,4

1 Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, New York
2 Department of Radiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
3 Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
4 Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York

Fungal diseases are difficult to treat in immunosuppressed patients and, consequently, new approaches to therapy are urgently needed. One novel strategy is to use radioimmunotherapy (RIT) with fungal-binding monoclonal antibodies (mAbs) labeled with radionuclides. However, many fungi manifest extreme resistance to {gamma}-radiation, such that the doses of several thousand gray are required for 90% cell killing, whereas for mammalian cells the lethal dose is only a few gray. We compared the susceptibility of human pathogenic fungi Cryptococcus neoformans (CN) and Histoplasma capsulatum (HC) to external {gamma}-radiation and to the organism-specific mAbs 18B7 and 9C7, respectively, conjugated to 213Bi and 188Re radionuclides. Methods: CN and HC cells were irradiated with up to 8,000 Gy (137Cs source, 30 Gy/min). RIT of CN with 213Bi- and 188Re-labeled specific mAb and of HC with 188Re-labeled specific mAb used 0–1.2 MBq per 105 microbial cells. After irradiation or RIT, the cells were plated for colony-forming units (CFUs). Cellular dosimetry calculations were performed, and the pathway of cell death after irradiation was evaluated by flow cytometry. Results: Both CN and HC proved to be extremely resistant to {gamma}-radiation such that significant killing was observed only for doses of >4,000 Gy. In contrast, these cells were much more susceptible to killing by radiation delivered with a specific mAb, such that a 2-logarithm reduction in colony numbers was achieved by incubating them with 213Bi- and 188Re-labeled mAb 18B7 or with 188Re-9C7 mAb. Dosimetry calculations showed that RIT was ~1,000-fold more efficient in killing CN and ~100-fold more efficient in killing HC than {gamma}-radiation. Both {gamma}-radiation and RIT caused cell death via an apoptotic-like pathway with a higher percentage of apoptosis observed in RIT-treated cells. Conclusion: Conjugating a radioactive isotope to a fungal-specific antibody converted an immunoglobulin with no antifungal activity into a microbicidal molecule. RIT of fungal cells using specific antibodies labeled with {alpha}- and ß-emitting radioisotopes was significantly more efficient in killing CN and HC than {gamma}-radiation when based on the mean absorbed dose to the cell. These results strongly support the concept of using RIT as an antimicrobial modality.

Key Words: radioimmunotherapy • infection • dosimetry • pathogenic fungi




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
R. A. Bryan, X. Huang, A. Morgenstern, F. Bruchertseifer, A. Casadevall, and E. Dadachova
Radiofungicidal Effects of External Gamma Radiation and Antibody-Targeted Beta and Alpha Radiation on Cryptococcus neoformans
Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2232 - 2235.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Dadachova, R. A. Bryan, X. Huang, G. Ortiz, T. Moadel, and A. Casadevall
Comparative Evaluation of Capsular Polysaccharide-Specific IgM and IgG Antibodies and F(ab')2 and Fab Fragments as Delivery Vehicles for Radioimmunotherapy of Fungal Infection
Clin. Cancer Res., September 15, 2007; 13(18): 5629s - 5635s.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
R. Ikeda, F. Saito, M. Matsuo, K. Kurokawa, K. Sekimizu, M. Yamaguchi, and S. Kawamoto
Contribution of the Mannan Backbone of Cryptococcal Glucuronoxylomannan and a Glycolytic Enzyme of Staphylococcus aureus to Contact-Mediated Killing of Cryptococcus neoformans
J. Bacteriol., July 1, 2007; 189(13): 4815 - 4826.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. R. Martinez, R. A. Bryan, C. Apostolidis, A. Morgenstern, A. Casadevall, and E. Dadachova
Antibody-guided alpha radiation effectively damages fungal biofilms.
Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2132 - 2136.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. V.S.V. Neti and R. W. Howell
Log Normal Distribution of Cellular Uptake of Radioactivity: Implications for Biologic Responses to Radiopharmaceuticals
J. Nucl. Med., June 1, 2006; 47(6): 1049 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
R. A. Bryan, O. Zaragoza, T. Zhang, G. Ortiz, A. Casadevall, and E. Dadachova
Radiological Studies Reveal Radial Differences in the Architecture of the Polysaccharide Capsule of Cryptococcus neoformans
Eukaryot. Cell, February 1, 2005; 4(2): 465 - 475.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Dadachova, J. D. Nosanchuk, L. Shi, A. D. Schweitzer, A. Frenkel, J. S. Nosanchuk, and A. Casadevall
Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin
PNAS, October 12, 2004; 101(41): 14865 - 14870.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.